ArticleThe Lancet. Neurology2022
Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study.
Yves Dauvilliers et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this papertrialcites it